Risk stratification after myocardial infarction in the thrombolytic era

Current Opinion in Cardiology

Volumn 11, Issue 4, 1996, Pages 428-433

  Rutherford, John D ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; STREPTOKINASE;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TEST; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; IMAGING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; REVIEW; RISK; SURVIVAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COST-BENEFIT ANALYSIS; ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART; HEART CATHETERIZATION; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT; THROMBOLYTIC THERAPY;

EID: 0029904676     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199607000-00012     Document Type: Review

References (23)

1. Jha P, Deboer D, Sykora K, Naylor DC: Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol 1996, 27:1335-1342. Using population-based data, these investigators compared the hospital mortality rates of patients receiving lytic therapy with those of other patients with acute myocardial infarction in Ontario, Canada.
2. The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993, 329:673-682.
3. LATE (Late Assessment of Thrombolytic Efficacy) Study Group: Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1992, 342:759-766.
4. Merrilees M, Scott PJ, Norris RM: Prognosis after myocardial infarction: results of 15 year follow up. BMJ 1984, 288:356-359.
5. Hillis LD, Forman S, Braunwald E, and the Thrombolysis in Myocardial infarction (TIMI) Phase II Co-Investigators: Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1990, 16:313-315.
6. Lee KL, Woodlief LH, Topol EJ, Weaver D, Betriu A, Col J, et al.: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995, 91:1659-1668. For the 41,021 patients enrolled in GUSTO-I, relations between clinical descriptors routinely collected at initial presentation and death within 30 days were examined. A multivariable analysis identified age as the most significant factor influencing 30-day mortality rates (which were 1.1% in patients younger than 45 years of age and 20.5% in patients older than 75 years of age). Other factors associated with increased mortality were lower systolic blood pressure, higher Killip class, elevated heart rate, and anterior infarction.
7. The Multicenter Postinfarction Research Group: Risk stratification and survival after myocardial infarction. N Engl J Med 1983, 309:331-336.
8. Kulick DL, Rahimtoola SH: Risk stratification in survivors of acute myocardial infarction: routine cardiac catheterization and angiography is a reasonable approach in most patients. Am Heart J 1991, 121:641-656.
9. Stack RS, Phillips HR, Grierson DS, Behar VS, Kong Y, Peter RH, et al.: Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. J Clin Invest 1983, 72:84-95.
10. Rutherford JD, Braunwald E: Chronic ischemic heart disease. In Heart Disease: A Textbook of Cardiovascular Medicine, edn 4. Edited by Braunwald E. Philadelphia: W.B. Saunders; 1992:1292-1364.
11. Hillis LD, Rutherford JD: Coronary angioplasty compared with bypass grafting [editorial]. N Engl J Med 1994, 331:1086-1087.
12. Pitt B: Evaluation of the postinfarct patient. Circulation 1995, 91:1855-1860. This current perspective on the evaluation of the patient after infarction. Examines coronary arteriography, noninvasive stress testing, and clinical findings and presents an algorithm for predicting ischemic events after acute myocardial infarction.
13. Schulman SP, Achuff SC, Griffith LSC, O'Neal Humphries J, Taylor GJ, Mellits ED, et al.: Prognostic cardiac catheterization variables in survivors of acute myocardial infarction: a five year prospective study. J Am Coll Cardiol 1988, 11:1164-1172.
14. Lamas GA, Flaker GC, Mitchell G, Smith SC, Gersh BJ, Wun C-C, et al.: Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation 1995, 92:1101-1109. In the Survival and Ventricular Enlargement (SAVE) study, the patency of the infarction-related artery was established in 946 patients before random assignment. Infarction related artery patency within 16 days after myocardial infarction was found to predict a favorable clinical outcome independent of the number of obstructed coronary arteries or of left ventricular function. The beneficial affect of angiotensin-converting enzyme inhibition was independent of the patency of the infarction-related artery. These findings suggest the need for additional clinical trials of late reperfusion in patients with myocardial infarction.
15. Popovic AD, Neskovic AN, Babic R, Obradovic V, Bozinovic L, Marinkovic J, et al.: Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction: serial echocardiographic follow-up. Circulation 1994, 90:800-807.
16. The TIMI Research Group: Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. JAMA 1988, 260:2849-2858.
17. The TIMI Study Group: Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1989, 320:618-627.
18. De Coster PM, Chierchia S, Davies GJ, Hackett D, Fragasso G, Maseri A: Combined effects of nitrates on the coronary and peripheral circulation in exercise-induced ischemia. Circulation 1990, 81:1881-1886.
19. Krone RJ: The role of risk stratification in the early management of a myocardial infarction. Ann Intern Med 1992, 116:223-237.
20. 201TI tomography in patients after acute myocardial infarction to identify higher-risk patients. Risk was best predicted by the absolute extent of ischemia and ejection fraction.
21. 99mTc-sestamibi single photon emission computed tomographic imaging to detect residual ischemia within 14 days of acute myocardial infarction. The number of ischemic defects was the only significant correlate of future events; it appeared to be better than clinical data, symptoms, and stress ECG in predicting subsequent cardiac events.
22. Gill JB, Cairns JA, Roberts RS, Costantini BA, Sealey BJ, Fallen EF, Tomlinson CW, Gent M: Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996, 334:65-70. The overall incidence of myocardial ischemia detected by ambulatory ECG monitoring 5 to 7 days after acute myocardial infarction was 23%. The mortality rates at 1 year were 11.6% in patients with ischemia and 3.9% in patients without ischemia. Myocardial ischemia detected by ambulatory ECG monitoring was common early after acute myocardial infarction and provided prognostic information beyond that available from standard clinical information.
23. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K, Boudillon PDV, Feigenbaum H: Low-dose dobutamine echocardiography detects reversible function after thrombolytic therapy of acute myocardial infarction. Circulation 1993, 88:405-415.